Dejan K Filipas

Thrilled to publish first results from a study that started almost 8 years ago: standardized morbidity & PROMs reporting after #RC. Short-term morbidity does not appear to impact 6-mo #HRQOL. eu-openscience.europeanurology.com/article/S2666-… @m_koelker @jakobfelin @mvdeimling @apachollek @fluebbersmeyer

Check out our collaborative effort to develop evidence-based clinical guidance on using @OptilumeDCB for #urethralstrictures. Promising device, but more data is needed for tx beyond @FDA approved and @Uroweb / @AmerUrological recommended indications. sciencedirect.com/science/articl…

Congrats to @mwvetterlein on a brilliant MANTA bulbar urethroplasty at IMORU XI! 3 days of top-notch live reconstructive surgeries here in Hamburg. Truly a world-class meeting. @UKEHamburg #Urology #LiveSurgery #Urethroplasty

The @IMORU 2025 program is set! Join us at @UKEHamburg for 20 live & 14 semi-live surgeries, expert lectures & interactive discussions with 30+ top international reconstructive surgeons. Register now: imoru.de/registration #IMORU2025

Patient satisfaction suggests perineal urethrostomy shouldn’t be just a last resort for complex stricture cases or elderly patients. Check out our latest paper in @JUrology doi.org/10.1097/JU.000… @mwvetterlein @DrShariat @EAU_YAURecon @SocietyGURS @UKEHamburg

Excited to share our latest work on female non-obstetric urogenital fistula repair! We dive into long-term patient-reported outcomes and provide a comprehensive review. Proud to collaborate with @mwvetterlein @DrShariat @UKEHamburg on this important work. R. Dahlem, M. Fisch.

Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism go.nature.com/3X2vUjx

Study notes increasing trends in non-operative management for small renal masses. Findings show significant variances in expectant management and focal ablation by year of diagnosis and race. From @DkFilipas et al. Read here: oxford.ly/4bpfKEU

Explore our latest study on how the COVID-19 pandemic has led to workflow improvements in prostate cancer care, significantly optimizing the time from diagnosis to counseling. Read more at: doi.org/10.1080/136855… @dr_steuber @Tilki_De @MartiniKlinik

Midlife baseline PSA as a predictor of lethal #ProstateCancer: Racial differences between Black and White men. Presented by @ChiarelliGiuse @HumanitasMilano. #AUA24 written coverage by @RKSayyid @UofT > bit.ly/3y5N8SM

In cN+ #BladderCancer treated with cisplatin-based induction CTX followed by RC we found no difference in #PathologicalResponse and OS/CSS between delivering three and four cycles - @mvdeimling @LAUrology_NL et al doi.org/10.1111/bju.16…

We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper authors.elsevier.com/a/1iOuo5YR3Cap… @mwvetterlein @DrShariat @MichaelRink_MD @JakobFelin @M_Koelker @VMS78880496 @FredKoenig @PAEGild

Articles in Press: The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality buff.ly/4b1TyRY @mdlabban @EdoardoBeatrici @DkFilipas @DrChoueiri @adamkibel_uro @Putnam_Cole @qdtrinh #UroSoMe

In a News and Views now published online, Jakob Klemm, Ekaterina Laukhtina & Shahrokh Shariat discuss a trial of addition of nivolumab to neoadjuvant therapy for muscle-invasive #bladdercancer with results published in @NatureMedicine: nature.com/articles/s4157…

Hot off the press in @JNCI_Now 🌏 Recognition of #Climatechange as a personal health threat is significantly associated w cancer screening intent - thx for the collaboration @JasonZhiyuQian @EdoardoBeatrici @qdtrinh @adamkibel_uro @hiyer_epi @Putnam_Cole academic.oup.com/jnci/advance-a…

Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data Base buff.ly/489z0oc @EdoardoBeatrici @mdlabban @DkFilipas @GLughezzani @NBuffi @adamkibel_uro @Putnam_Cole @qdtrinh

Online now: Continent Diversion is Losing its Momentum: a Nationwide Trend Analysis from Germany 2005–2021 by @JakobFelin @mwvetterlein et al. bjui-journals.onlinelibrary.wiley.com/doi/abs/10.111…

@drphil_urology @qdtrinh @Putnam_Cole Great work by our team @EdoardoBeatrici @Nolazco_JI @JasonZhiyuQian @benvstone @mdlabban Thank you for the great collaboration @drphil_urology

getting better at #activesurveillance for small renal masses 90% improvement since 2010, but only 10% getting AS great work f @DkFilipas @qdtrinh @Putnam_Cole The National Utilization of Non-Operative Management for Small Renal Masses Over 10 Years pubmed.ncbi.nlm.nih.gov/37802923/

No long‐term difference in patient reported QoL between NHB and NHW men after prostatectomy but significant difference before surgery and up to 12 months after surgery onlinelibrary.wiley.com/share/author/W……… Thanks to @BWHUrology @UKEHamburg @CSPH_BWH